NS3 helicases as drug targets

Current Chemical Biology

Volumn 3, Issue 3, 2009, Pages 334-342

  Chène, Patrick ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Dengue virus; Hepatitis C virus; NS3 helicase; West nile virus

Indexed keywords

ADENOSINE DIPHOSPHATE; APOLIPOPROTEIN; DEAD BOX PROTEIN; HELICASE; NONSTRUCTURAL PROTEIN 3; NUCLEIC ACID; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELF 4A; UNCLASSIFIED DRUG;

BINDING SITE; CATALYSIS; DENGUE; ENZYME ACTIVITY; ENZYME STRUCTURE; EPIDEMIC ENCEPHALITIS; FLAVIVIRUS; HEPATITIS C; HEPATITIS C VIRUS; KUNJIN VIRUS; MURRAY VALLEY ENCEPHALITIS VIRUS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TARGETING; REVIEW; SEQUENCE ALIGNMENT; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION; YELLOW FEVER;

DENGUE VIRUS; FLAVIVIRIDAE; HEPATITIS C VIRUS; JAPANESE ENCEPHALITIS VIRUS; WEST NILE VIRUS;

EID: 70449675063     PISSN: 18723136     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231309789054850     Document Type: Review

References (63)

1. th ed, Philadelphia: Lippincott Williams & Wilkins. 2007.
2. Baldo V, Baldovin T, Trivello R, Floreani A. Epidemiology of HCV infection. Curr Pharm Des 2008; 14: 1646-1654
3. Gould EA, Solomon T. Pathogenic flaviviruses. Lancet 2008; 371: 500-509
4. Beaulieu PL. Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections. Curr Opin Investig Drugs 2007; 8: 614-634
5. Jensen DM, Ascione A. Future directions in therapy for chronic hepatitis C. Antiviral Ther 2008; 13: 31-36 (Pubitemid 351542496)
6. Malet H, Massé N, Selisko B, et al. The flavivirus polymerase as a target for drug discovery. Antiviral Res 2008; 80: 23-35.
7. Sampath A, Padmanabhan R. Molecular targets for flavivirus drug discovery. Antiviral Res 2009; 81: 6-15.
8. Lescar J, Luo D, Xu T, et al. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from dengue virus as a target. Antiviral Res 2008; 80: 94-101.
9. Lopez-Labrador FX. Hepatitis C virus NS3/4A protease inhibitors. Recent Pat. Antiinfect Drug Discov 2008; 3: 157-167
10. Sheldon J, Barreiro P, Vincent V. Novel protease and polymerase inhibitors for the treatment of hepatitis C infections. Expert Opin Investig Drugs 2007; 16: 1171-1181 (Pubitemid 47317010)
11. Bordeleau ME, Cencic R, Linqvist L, et al. RNA-mediated sequestration of the RNA helicase EIF4A by pateamine inhibits translation initiation. Chem Biol 2006; 13: 1287-1295 (Pubitemid 44932234)
12. Linqvist L, Oberer M, Reibarkh M, et al. Selective pharmacological targeting of a DEAD box RNA helicase. PloS ONE 2008; 3: e1583. (Pubitemid 351843802)
13. Eoff RL, Raney KD. Helicase-catalysed translocation and strand separation. Biochem Soc Transac 2005; 33: 1474-1478
14. Dalvit C, Fogliatto GP, Stewart A, Veronesi M, Stockman B. WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability. J Biomol NMR 2001; 21: 349-359 (Pubitemid 34071389)
15. Dumont S, Cheng W, Serebrov V, et al. RNA translocation and unwinding mechanism of HCV NS3 helicase and its coordination by ATP. Nature 2006; 439: 105-108 (Pubitemid 43053637)
16. Levin MK, Gurjar M, Patel SS. A brownian motor mechanism of translocation and strand separation by hepatitis C virus helicase. Nat Struct Mol Biol 2005; 12: 429-435 (Pubitemid 43085903)
17. Patel SS, Donmez I. Mechanisms of helicases. J Biol Chem 2006; 281: 18265-18268
18. Serebrov V, Pyle AM. Periodic cycles of RNA unwinding and pausing by hepatitis C virus NS3 helicase. Nature 2004; 430: 476-480 (Pubitemid 38987912)
19. Singleton MR, Dillingham MS, Wigley DB. Structure and mechanism of helicases and nucleic acid translocases. Ann Rev Biochem 2007; 76: 23-50.
20. Cordin O, Banroques J, Tanner NK, Linder P. The DEAD-box protein family of RNA helicases. Gene 2006; 367: 17-37. (Pubitemid 43286737)
21. Walker JE, Saraste M, Runswick MJ, Gay NJ. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J 1982; 1: 945-951
22. Caruthers JM, McKay DB. Helicase structure and mechanism. Curr Opin Struct Biol 2002; 12: 123-133
23. Jankowsky E, Fairman ME. RNA helicases - one fold many functions. Curr Opin Struct Biol 2007; 17: 316-324 (Pubitemid 47021361)
24. Yamashita T, Unno H, Mori Y, et al. Crystal structure of the catalytic domain of the Japanese encephalitis virus NS3 helicase/ nucleoside triphosphatase at a resolution of 1.8 Å. Virology 2008; 373: 426-436
25. Luo D, Xu T, Watson RP, et al. Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein. EMBO J 2008; 27: 3209-3219
26. Frick DN, Rypma RS, Lam AMI, Frenz CM. Electrostatic analysis of hepatitis C virus NS3 helicase reveals both active and allosteric site locations. Nucleic Acids Res 2004; 32: 5519-5528
27. Xu T, Sampath A, Chao A, et al. Structure of the Dengue virus helicase/nucleoside triphosphatase catalytic domain at a resolution of 2.4 Å. J Virol 2005; 79: 10278-10288
28. Ishido S, Fujita T, Hotta H. Complex of NS5B with NS3 and NS4A proteins of hepatitis C virus. Biochem Biophys Res Comm 1998; 244: 35-40. (Pubitemid 28419896)
29. Jennings TA, Chen Y, Sikora D, et al. RNA unwinding activity of the hepatitis C virus NS3 helicase is modulated by the NS5B polymerase. Biochemistry 2008; 47: 1126-1135
30. Zhang C, Cai Z, Kim YC, et al. Stimulation of hepatitis C virus (HCV) nonstructural protein 3 (NS3) helicase activity by the NS3 protease domain and by HCV RNA-dependent polymerase. J Virol 2005; 79: 8687-8697 (Pubitemid 40934779)
31. Luo D, Xu T, Hunke C, Grüber G, Vasudevan SG, Lescar J. Crystal structure of the NS3 protease-helicase from Dengue virus. J Virol 2008; 82: 173-183 (Pubitemid 350309134)
32. Yao N, Reichert P, Taremi SS, Prosise WW, Weber PC. Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase. Structure 1999; 7: 1353-1363 (Pubitemid 29529876)
33. Bera AK, Kuhn RJ, Smith JL. Functional characterization of cis and trans activity of the flavivirus NS2B-NS3 protease. J Biol Chem 2007; 282: 12883-12892
34. Frick DN, Rypma RS, Lam AMI, Gu B. The nonstructural protein 3 protease/helicase requires an intact protease domain to unwind duplex RNA efficiently. J Biol Chem 2004; 279: 1269-1280 (Pubitemid 38082651)
35. Gu B, Pruss CM, Gates AT, Khandekar SS. The RNA-unwinding activity of hepatitis C virus non-structural protein 3 (NS3) is positively modulated by its protease domain. Protein Pept Lett 2005; 12: 315-321 (Pubitemid 40727850)
36. Yon C, Teramoto T, Mueller N, et al. Modulation of the nucleoside triphosphatase/RNA helicase and 5′-RNA triphosphatase activities of Dengue virus type 2 nonstructural protein 3 (NS3) by interaction with NS5, the RNA-dependent RNA polymerase. J Biol Chem 2005; 280: 27412-27419
37. Levin MK, Wang YH, Patel SS. The functional interaction of the hepatitis C virus helicase molecules is responsible for unwinding processivity. J Biol Chem 2004; 279: 26005-26012
38. Beran RKF, Serebrov V, Pyle AM. The serine protease domain of hepatitis C viral NS3 activates RNA helicase activity by promoting the binding of RNA substrate. J Biol Chem 2007; 282: 34913-34920 (Pubitemid 350232430)
39. Gallinari P, Paolini C, Brennan D, Nardi C, Steinkühler C, De Francesco R. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A. Biochemistry 1999; 38: 5620-5632 (Pubitemid 129514870)
40. Kuang WF, Lin YC, Jean F, et al. Hepatitis C virus NS3 RNA helicase activity is modulated by the two domains of NS3 and NS4A. Biochem Biophys Res Comm 2004; 317: 211-217 (Pubitemid 38401986)
41. Pang PS, Jankowsky E, Planet PJ, Pyle AM. The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding activity. EMBO J 2002; 21: 1168-1176
42. Chernov AV, Shiryaev SA, Aleshin AE, et al. The two-component NS2B-NS3 proteinase represses DNA unwinding activity of the West Nile virus NS3 helicase. J Biol Chem 2008; 283: 17270-17278
43. Wu J, Bera AK, Kuhn RJ, Smith JL. Structure of the flavivirus helicase: implications for catalytic activity, protein interactions, and proteolytic processing. J Virol 2005; 79: 10268-10277 (Pubitemid 41098568)
44. Davis AM, Teague SJ. Hydrogen bonding, hydrophobic interactions, and failure of the rigid receptor hypothesis. Angew Chem Int Ed 1999; 38: 736-749 (Pubitemid 29146588)
45. Olsson TSG, Williams MA, Pitt WR, Ladbury JE. The thermodynamics of protein-ligand interaction and solvation: insights for ligand design. J Mol Biol 2008; 384: 1002-1017
46. Kim DW, Kim J, Gwack Y, Han JH, Choe J. Mutational analysis of the hepatitis C virus RNA helicase. J Virol 1997; 71: 9400-9409 (Pubitemid 27492383)
47. Matusan AE, Pryor MJ, Davidson AD, Wright PJ. Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicases motifs: effects on enzyme activity and virus replication. J Virol 2001; 75: 9633-9643
48. Tai CL, Pan WC, Liaw SH, Yang UC, Hwang LH, Chen DS. Structure- based mutational analysis of the hepatitis C virus NS3 helicase. J Virol 2001; 75: 8289-8297
49. Sampath A, Xu T, Chao A, Luo D, Lescar J, Vasudevan SG. Structure- based mutational analysis of the NS3 helicase from Dengue virus. J Virol 2006; 80: 6686-6690
50. Porter DJT, Preugschat F. Strand-separating activity of hepatitis C virus helicase in the absence of ATP. Biochemistry 2000; 39: 5166-5173
51. Kim JL, Morgenstern KA, Griffith JP, et al. Hepatitis C virus RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure 1998; 6: 89-100.
52. Maga G, Gemma S, Fattorusso C, et al. Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663. Biochemistry 2005; 44: 9637-9644
53. Velankar SS, Soultanas P, Dillingham MS, Subramanya HS, Wigley DB. Crystal structures of complexes of PcrA DNA helicase with a DNA substrate indicate and inchworm mechanism. Cell 1999; 97: 75-84. (Pubitemid 29165891)
54. Dubaele S, Jahnke W, Schoepfer J, Fuchs J, Chène P. Inhibition of DNA helicases with DNA-competitive inhibitors. Bioorg Med Chem Lett 2006; 16: 923-927 (Pubitemid 43059853)
55. Lo MC, Aulabaugh A, Jin G, et al. Evaluation of fluorescencebased thermal shift assays for hit identification in drug discovery. Anal Biochem 2004; 332: 153-159 (Pubitemid 39099482)
56. Mancini EJ, Assenberg R, Verma A, et al. Structure of the Murray Valley encephalitis virus RNA helicase at 1.9 Å resolution. Protein Sci 2007; 16: 2294-2300
57. Mastrangelo E, Milani M, Bollati M, et al. Crystal structure and activity of Kunjin virus NS3 helicase; protease and helicase domain assembly in the full-length NS3 protein. J Mol Biol 2007; 372: 444-455
58. Speroni S, De Colibus L, Mastrangelo E, et al. Structure and biochemical analysis of Kokobera virus helicase. Proteins 2007; 70: 1120-1123
59. McIntosh DB, Wooley DG, Vilsen B, Andersen JP. Mutagenesis of segment 487Phe-Ser-Arg-Asp-Arg-Lys492 of sarcoplasmic reticulum Ca2+-ATPase produces pumps defective in ATP binding. J Biol Chem 1996; 271: 25778-25789 (Pubitemid 26347405)
60. Cho HS, Ha NC, Kang LW, et al. Crystal structure of RNA helicase from genotype 1b hepatitis C virus. J Biol Chem 1998; 273: 15045-15052
61. Yao N, Hesson T, Cable M, et al. Structure of the hepatitis C virus RNA helicase domain. Nat Struct Biol 1997; 4: 463-467. (Pubitemid 27263599)
62. Notredame C, Higgins D, Heringa J. T-Coffee: A novel method for multiple sequence alignments. J Mol Biol 2000; 302: 205-217
63. Hendlich M, Rippman F, Barnickel G. LIGSITE: automatic and efficient detection of potential small molecule-binding sites in proteins. J Mol Graph Model 1997; 15: 359-363 (Pubitemid 28409807)